There are two pieces of good news for embryonic stem cell science in this report from the The Australian. Firstly, a Melbourne company is allowing free, unconditional access to a new embryonic stem cell line, with more to come in the future: “The company planned to release five more stem-cell lines over the next two years.” This is an interesting varient on open source development strategies; the company plans to profit indirectly from its altruism. Secondly, this line only cost $100,000 to develop! This comparatively low price point (itself a sign of advancing technological prowess in the field) indicates that we should be seeing many more lines becoming available in the future – an essential condition for real progress in regenerative medicine.
View the Article Under Discussion: http://www.theaustralian.news.com.au/common/story_page/0,5744,11395996%255E30417,00.html
Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/
http://www.longevitymeme.org/news/view_news_item.cfm?news_id=1317
